StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) stock

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.40−0.08 (-16.67%)

Close on Nov 12, 2026Market cap $2.07MP/E –Yield –

Jaguar Health gross margin

Gross margin is gross profit as a percentage of revenue.

Jaguar Health's gross margin for the twelve months ending Jun 30, 2026 was 82.3%. For fiscal 2025 it was 67.2%, against 83.3% the year before. The highest annual figure on record is 83.3% in fiscal 2024.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202567.2%−16.1
FY2024Dec 31, 202483.3%+4.1
FY2023Dec 31, 202379.1%−4.0
FY2022Dec 31, 202283.1%+36.9
FY2021Dec 31, 202146.2%−18.9
FY2020Dec 31, 202065.1%+31.1
FY2019Dec 31, 201933.9%−3.4
FY2018Dec 31, 201837.4%−42.4
FY2017Dec 31, 201779.8%+16.5
FY2016Dec 31, 201663.3%+11.1
FY2015Dec 31, 201552.2%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202615.8%−66.5
Q1 FY2026Mar 31, 202694.3%+17.5
Q4 FY2025Dec 31, 202532.0%−52.1
Q3 FY2025Sep 30, 202582.7%+0.2
Q2 FY2025Jun 30, 202582.3%−2.0
Q1 FY2025Mar 31, 202576.7%−5.0
Q4 FY2024Dec 31, 202484.1%+14.0
Q3 FY2024Sep 30, 202482.6%+0.9
Q2 FY2024Jun 30, 202484.3%+14.9
Q1 FY2024Mar 31, 202481.7%+10.0
Q4 FY2023Dec 31, 202370.1%+2.7
Q3 FY2023Sep 30, 202381.7%+59.5
Q4 FY2020Dec 31, 202069.4%+18.7
Q3 FY2020Sep 30, 202071.7%+69.2
Q2 FY2020Jun 30, 202067.4%+41.3
Q1 FY2020Mar 31, 202022.2%−23.4
Q4 FY2019Dec 31, 201950.7%+10.7
Q3 FY2019Sep 30, 20192.6%−32.4
Q2 FY2019Jun 30, 201926.1%−32.8
Q1 FY2019Mar 31, 201945.6%−35.7
Q4 FY2018Dec 31, 201840.0%−57.2
Q3 FY2018Sep 30, 201834.9%−63.1
Q4 FY2017Dec 31, 201758.9%+11.2
Q3 FY2017Sep 30, 201781.3%+0.8
Q2 FY2017Jun 30, 201797.2%+33.0
Q1 FY2017Mar 31, 201798.0%–
Q4 FY2016Dec 31, 201647.7%–
Q3 FY2016Sep 30, 201680.4%–
Q2 FY2016Jun 30, 201664.2%–

More Jaguar Health figures

See a number that looks wrong?